๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

New cancer drugs targeting the biosynthesis of estrogens and androgens

โœ Scribed by Donald Poirier

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
196 KB
Volume
69
Category
Article
ISSN
0272-4391

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The discovery and validation of new drug
The discovery and validation of new drug targets in cancer
โœ Sara A Courtneidge; Greg D Plowman ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 672 KB

Advances in our understanding of the signal transduction pathways involved in cellular growth control have provided several new strategies for cancer therapy. Recent advances now make it possible to develop selective inhibitors targeting genomic instability, the growth, survival, and invasion of the

Genomics and the discovery of new drug t
Genomics and the discovery of new drug targets
โœ David A Jones; Frank A Fitzpatrick ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 84 KB

Molecular medicine and genomics technologies are inseparable for defining new molecular targets. cDNA databases and elementary informatic tools provide instantaneous glimpses of gene families or tissue-restricted expression patterns as a means of new target identification. In addition, cDNA microarr

A demonstration of androgen and estrogen
A demonstration of androgen and estrogen receptors in a human breast cancer using a new protamine sulfate assay
โœ Marc Lippman; Karen Huff ๐Ÿ“‚ Article ๐Ÿ“… 1976 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 514 KB

Separate receptors for estrogen and androgen are demonstrated in cells from metastic human breast cancer. By criteria of binding affinity, number of binding sites, and specificity of the receptor for different steroids, the receptors are shown to be distinguishable. The protamine sulfate receptor as